Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China.
Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of China.
Biomark Med. 2022 Nov;16(16):1181-1191. doi: 10.2217/bmm-2022-0349. Epub 2023 Jan 23.
Multiple myeloma (MM) remains incurable despite advances in current treatment. Patients with MM exhibit significant variations in their prognosis and survival. Recently, genetic abnormalities, such as chromosomal variations and gene mutations, have been increasingly recognized in MM. Therefore, better prognostic indicators of MM are required for the diagnosis and treatment of patients with MM. ncRNAs are non-protein-coding transcripts that regulate gene expression at the post-transcriptional level. Deregulation of ncRNAs affects cell cycle progression, cancer cell invasion and metastasis. The abnormal expression of these ncRNAs is also critical for the pathogenesis of several cancers, including MM. Hence, this review aims to discuss the recent findings on the role of regulatory ncRNAs and evaluate their potential value in MM.
多发性骨髓瘤(MM)尽管当前的治疗方法取得了进展,但仍然无法治愈。MM 患者的预后和生存存在显著差异。最近,MM 中越来越多的遗传异常,如染色体变异和基因突变,已经被认识到。因此,需要更好的 MM 预后指标来诊断和治疗 MM 患者。ncRNAs 是不编码蛋白质的转录本,可在转录后水平调节基因表达。ncRNAs 的失调会影响细胞周期进程、癌细胞侵袭和转移。这些 ncRNAs 的异常表达对于包括 MM 在内的几种癌症的发病机制也至关重要。因此,本综述旨在讨论调控 ncRNAs 的最新研究结果,并评估其在 MM 中的潜在价值。